• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Huipeng, SU Zhigui, CHEN Minglei, MENG Fanfei, SUN Minjie, WANG Yan, ZHANG Can, PING Qineng. Preparation and characterization of nanostructured lipid carriers with difference in particle size[J]. Journal of China Pharmaceutical University, 2015, 46(4): 436-443. DOI: 10.11665/j.issn.1000-5048.20150409
Citation: LI Huipeng, SU Zhigui, CHEN Minglei, MENG Fanfei, SUN Minjie, WANG Yan, ZHANG Can, PING Qineng. Preparation and characterization of nanostructured lipid carriers with difference in particle size[J]. Journal of China Pharmaceutical University, 2015, 46(4): 436-443. DOI: 10.11665/j.issn.1000-5048.20150409
shu

Preparation and characterization of nanostructured lipid carriers with difference in particle size

More Information
    Graphical Abstract
    • Abstract
  • To construct nanostructured lipid carriers(NLCs)with different particle sizes but the same other physicochemical properties, central composite design was adopted. Coumarin-6(C-6)was selected as the model drug due to its high lipophilicity and high fluorescence intensity. Physicochemical properties of NLCs with 100 nm, 200 nm and 300 nm in particle size could remain stable during certain time in K-R solution and PBS. Release experiments in vitro showed that cumulative release of C-6 in NLCs was less than 7% after 24 h. The MTT assay indicated that both blank NLCs and C-6 loaded NLCs showed low toxicity. To confirm the integrity of NLCs in gastrointestinal tract, DiR-loaded NLCs were prepared and the distribution in vivo was monitored by fluorescence imaging. After 6 h oral administration, intact DiR-loaded NLCs could stiu be found, suggesting that NLCs could be used to characterize the uptake in gastrointestinal tract.
    • FullText(HTML)
    • References (15)
  • [1]
    Patel VF,Liu F,Brown MB.Advances in oral transmucosal drug delivery[J].J Control Release,2011,153(2):106-116.
    [2]
    Ensign LM,Cone R,Hanes J.Oral drug delivery with polymeric nanoparticles:the gastrointestinal mucus barriers[J].Adv Drug Deliver Rev,2012,64(6):557-570.
    [3]
    Schenk M,Mueller C.The mucosal immune system at the gastrointestinal barrier[J].Best Pract Res Clin Gastroenterol,2008,22(6):391-409.
    [4]
    Yuan H,Wang LL,Du YZ,et al.Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification[J].Colloid Surface B,2007,60(2):174-179.
    [5]
    Jung T,Kamm W,Breitenbach A,et al.Biodegradable nanoparticles for oral delivery of peptides:is there a role for polymers to affect mucosal uptake[J]? Eur J Pharm Biopharm,2000,50(1):147-160.
    [6]
    Des Rieux A,Ragnarsson EGE,GullbergE,et al.Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium[J].Eur J Pharm Sci,2005,25(4/5):455-465.
    [7]
    Joshi M,Patravale V.Nanostructured lipid carrier(NLC)based gel of celecoxib[J].Int J Pharm,2008,346(1/2):124-132.
    [8]
    Albanese A,Tang PS,Chan WCW.The effect of nanoparticle size,shape,and surface chemistry on biological systems[J].Annu Rev Biomed Eng,2012,14:1-16.
    [9]
    Muller RH,Petersen RD,HornmossA,et al.Nanostructured lipid carriers(NLC)in cosmetic dermal products[J].Adv Drug Deliver Rev,2007,59(6):522-530.
    [10]
    Chen HB,Zheng Y,Tian G,et al.Oraldelivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy[J].Nanoscale Res Lett,2011,6(1):4.
    [11]
    Muller RH,Radtke M,Wissing SA.Nanostructured lipid matrices for improved microencapsulation of drugs[J].Int J Pharm,2002,242(1/2):121-128.
    [12]
    Souto EB,Mehnert W,Muller RH.Polymorphic behavior of Compritol(R)888 ATO as bulk lipid and as SLN and NLC[J] J Microencapsul,2006,23(4):417-433.
    [13]
    Pardeike J,Hommoss A,Muller RH.Lipid nanoparticles(SLN,NLC)in cosmetic and pharmaceutical dermal products[J].Int J Pharm,2009,366(1/2):170-84.
    [14]
    Shi YP,Su ZG,Li S,et al.Multisteptargeted nanodrug delivery system aiming at leukemic stem cells and minimal residual disease[J].Mol Pharm,2013,10(6):2479-2489.
    [15]
    Su ZG,Shi YP,Xiao YY,et al.Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrierin vivo after optimization[J].Int J Pharm,2013,447(1/2):281-292.
    • Related Articles

  • Related Articles

    [1]YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
    [2]WANG Songkai, ZOU Yuchen, SUN Shipeng, YAN Zhiye, TANG Weiwei, LI Ping, LI Bin. Recent advances in mass spectrometry imaging and its application in drug research[J]. Journal of China Pharmaceutical University, 2023, 54(6): 653-661. DOI: 10.11665/j.issn.1000-5048.2023091901
    [3]WEI Naijie, WANG Guangji, ZHANG Jingwei. Advances in research on visualization of living cell drugs in vivo[J]. Journal of China Pharmaceutical University, 2022, 53(2): 156-163. DOI: 10.11665/j.issn.1000-5048.20220204
    [4]LIU Yang, WANG Zian, JIANG Yifei, JI Min, WANG Peng. Preparation and characterization of the second near-infrared window fluorescent/photoacoustic imaging liposomes[J]. Journal of China Pharmaceutical University, 2019, 50(5): 560-564. DOI: 10.11665/j.issn.1000-5048.20190508
    [5]WANG Zian, LIU Yang, WANG Peng, JIANG Yifei, JI Min. Preparation, in vitro imaging and antitumor activity of the second near-infrared imaging drug-loaded liposomes[J]. Journal of China Pharmaceutical University, 2019, 50(4): 438-443. DOI: 10.11665/j.issn.1000-5048.20190408
    [6]LI Xinxin, WU Huan, WANG Chen, FENG Fang. Mass spectrometry imaging and its application in pharmaceutical sciences[J]. Journal of China Pharmaceutical University, 2014, 45(1): 17-25. DOI: 10.11665/j.issn.1000-5048.20140103
    [7]CUI Ye, WANG Lu, SUN Qiong, ZHANG Can. In vitro evaluation of cationic liposomes prepared with oligopeptide-based lipids for plasmid DNA delivery[J]. Journal of China Pharmaceutical University, 2013, 44(4): 328-333. DOI: 10.11665/j.issn.1000-5048.20130408
    [8]SONG Yi-ting, ZHOU Hong, SUN Wan-jin, GAO Yuan, LI Chao. Preparation and physicochemical characterization of a spray-dried lornoxicam self-microemulsifying system[J]. Journal of China Pharmaceutical University, 2012, 43(2): 137-141.
    [9]YU Jie, YE Chao, LI Chen-gui, CHEN Rong, HU Yu-zhu. Application progress of quantum dot-liposomes[J]. Journal of China Pharmaceutical University, 2011, 42(4): 380-384.
    [10]YUAN Xue, ZOU Chang, JIANG Li-ping, ZHANG Yun, CHEN Ya-li. In vitro stability of Endostar[J]. Journal of China Pharmaceutical University, 2009, 40(4): 359-363.

Catalog

    Get Citation
    PDF
    XML
    Article views (1261) PDF downloads (1465) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366190

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return